We compared the prediction accuracy for NAFLD diagnosis based on fibrinolytic indicators (TPA and PAI-1) with the prediction accuracy based on metabolic indicators (TC, HDL-C, LDL-C, ALT/AST), screened the more accurate one. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.